Plenty of biotech penny stock runners and short squeezes to watch this week…
Some have squeezed right out of penny stock territory. And short squeezes in higher-priced stocks could create more sympathy plays in my favorite low-priced stocks.
I love the volatility these moves create. They offer the potential for trades on the way up and the way down. But you must know how to trade the patterns.
And never let FOMO get the best of you.
Make your trading plan with an entry and exit, then stick to it. If you miss a trade, it’s not a big deal. There will always be another play. As long as you protect your capital and stay in the game…
Here are the top biotech penny stocks I’m watching this week and why.
NOBODY in the stock market is as smart as they want others to believe, the smartest ones are the ones who know they know nothing
— Timothy Sykes (@timothysykes) July 11, 2021
Top Biotech Penny Stocks to Watch
These are the top stocks on my watchlist. ‘Watch’ is the key word here. There’s no guarantee that there’ll be a trading opportunity. Remember, these stocks move FAST.
Before we get to my list of stocks to watch, here are a few of my top resources for penny stocks…
- If you’re new to penny stocks, start here with this FREE online guide.
- Ready to learn how to build your own stock watchlist? This post is for you.
- Discover how I find all the stocks on my watchlists here.
How do I find hot stocks? I use StocksToTrade every day. For me, it’s the best tool because I helped design it specifically for trading penny stocks. (I’m also an investor.) It has awesome charts, built-in scans, social media feeds, and so much more to help you do your research.
And its Breaking News Chat add-on feature is a game-changer in this hot market. It helped me make record profits in 2020.* Get a StockToTrade 14-day trial for only $7…
Or try it with the Breaking News Chat for only $17!
Now, let’s get to the top biotech penny stocks to watch this week…
Biotech Penny Stocks #1: Cybin Inc. (OTCQB: CLXPF)
CLXPF is a biotech company developing psychedelics as a treatment for neurological conditions.
On July 13 the company announced it filed its 13th patent application.
“Cybin has commenced the next phase of the company’s digital therapeutics platform which will better enable the evaluation of patient outcomes through a highly secure, patient-centered data analytics platform for better pre-and post-psychedelic treatments.
“The digital therapeutics platform, which is proprietary to Cybin and the subject of the company’s 13th patent application, adds another dimension to the company’s development programs.”
Read the full press release here.
The stock’s in an uptrend and with multiple gap-ups. I’ll watch it for a potential breakout over $3.
Biotech Penny Stocks #2: Predictive Technology Group, Inc. (OTCPK: PRED)
Predictive Technology develops human cellular and tissue-based products.
The stock’s uptrending since it filed a Form 8-K on June 21. And it’s held near its recent highs around 50 cents.
I’ll watch it to potentially breakout to new 52-week highs above $0.565. But if it breaks down, it could offer a dip-buy opportunity into a big panic.
Biotech Penny Stocks #3: AXIM Biotechnologies, Inc. (OTCQB: AXIM)
AXIM is a biotech that focuses on research and development to change oncology and COVID-19 diagnosis. The company is working on a COVID-19 rapid test and an early rapid test to detect cancer.
There’s no recent news on the company, but it’s in an uptrend and recently broke above $1. I’ll watch for a catalyst and high volume to potentially push AXIM to break out above $1.20.
Biotech Penny Stocks #4: Virpax Pharmaceuticals, Inc. (NASDAQ: VRPX)
VRPX develops non-opioid pain medications in spray and gel applications.
VRPX is trading higher than average volume since it squeezed shorts from the $4s to the $8s on July 7.
The stock was trading in the high $4s when I started writing this post — then it spiked quickly and squeezed to $7.27. Now it’s back to trading right around the edge of penny stock land in the $5s.
The stock has a low float of around two million shares. So it could make another volatile move, especially with a news catalyst. I’ll watch it to potentially squeeze higher.
Biotech Penny Stocks #5: Xenetic Biosciences, Inc. (NASDAQ: XBIO)
XBIO develops a T-cell platform to target tumors.
It’s another stock with no recent news. But it’s trading higher than average volume and was up over 20% on July 13.
The stock has a relatively low float of around eight million shares. Yep, it’s another stock I’ll watch for a volatile move. But again, I’d prefer to see a catalyst.
Biotech Penny Stocks #6: Creative Medical Technology Holdings, Inc. (OTCPK: CELZ)
CELZ develops stem cell treatments for various disorders.
It’s a favorite among traders on the Reddit penny stock page. But it’s the opposite of others on this watchlist — it has a massive float of around a billion shares. That’s typical for some low-priced sketchy OTCs.
That means it needs a ton of volume for a big move … but Reddit traders might be able to deliver that volume.
It’s a speculative watch for a breakout over 4 cents. Again, I’d like to see high volume and a catalyst before I plan a trade.
Biotech Penny Stocks #7: InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV)
NVIV develops scaffold implants to treat spinal cord injuries.
On July 13 the company announced the FDA accepted the preclinical module for its humanitarian device exemption (HDE) application.
“The HDE modular shell is comprised of three modules: the preclinical studies module, a manufacturing module and a clinical data module.”
The PR then says, “The preclinical module is the first module that the Company has submitted for review to the FDA. The HDE submission will not be complete until the manufacturing and clinical modules are also submitted.”
Read the full press release here.
The stock gapped up and had a morning spike after the news. Then it faded. I’ll watch this one for a potential morning panic dip-buy opportunity.
Biotech Penny Stocks #8: PharmaTher Holdings Ltd. (OTCQB: PHRRF)
PHRRF is another biotech in the psychedelic space. It develops ketamine products to treat neurological and pain disorders.
It’s another stock with no recent news. But stocks in the psychedelic space have seen increased volume and upward price movement recently.
I’m watching this one for a multi-day breakout above 81 cents.
Biotech Penny Stocks #9: Osmotica Pharmaceuticals plc (NASDAQ: OSMT)
OSMT develops ADHD, Parkinson’s, and multiple sclerosis medications.
The stock bounced and started to uptrend after it had a huge red day on June 25. The latest news on the company is from June 30 when it announced additions to its leadership team.
I think there are probably a lot of bag holders stuck in the stock from its big June 25 move. I’ll watch for a panic dip-buy opportunity.
Biotech Penny Stocks #10: Allena Pharmaceuticals, Inc. (NASDAQ: ALNA)
ALNA develops enzyme therapies to treat metabolic and kidney disorders.
On July 12 the company provided an update on its clinical development programs. The next day the stock had its first green day. It popped on increased volume midday. It could be a sympathy play to VRPX.
I’ll watch it to potentially continue higher. The stock isn’t very volatile — I’ll swing for singles with any potential trades.
Get the List of Penny Stocks I’m Watching Delivered to Your Inbox
Want to know which stocks I’m watching each week? Subscribe to my no-cost watchlist. I’ll send my top penny stocks to watch right to your inbox every week. It can help you learn the process I follow for every stock.
I’ll say it again … The stocks on my watchlist aren’t an automatic buy. Remember to do your own due diligence and research. If you’re trading without a trading plan, you’re gambling. Don’t be a degenerate gambler — trade smart!
👉🏼 SUBSCRIBE to my no-cost weekly stock watchlist here.
Conclusion
Biotech penny stocks are stocks of small, developmental companies. These companies are usually desperate for cash. They need it to continue developing products and for testing and trials. Trade them with caution…
They’re known to be extremely volatile. They can have huge price swings. One minute they’re flying high on positive news — the next they’re down due to bad trial results, side effects, or stock dilution.
If you’re prepared to take advantage of the price swings, these stocks can offer great trading opportunities…
In my Trading Challenge chat room, my students and I talk about the hottest penny stocks. And many top traders who got their start in the Challenge are now chat moderators who answer questions and help out new students.
If you want to join a community of top traders, apply for my Trading Challenge. I don’t accept everyone. I only want the most dedicated students who are willing to put in the time and effort it takes to become my next top student. Could it be you?
What do you think of these biotech penny stocks to watch? Let me know in the comments … I love to hear from you!
Disclaimers
*Please note that these kinds of trading results are not typical and do not reflect the experience of the majority of individuals using our products. From January 1, 2020, to December 31, 2020, typical users of the products and services offered by this website reported earning, on average, an estimated $49.91 in profit. It takes years of dedication, hard work, and discipline to learn how to trade. Individual results will vary. Trading is inherently risky. Before making any trades, remember to do your due diligence and never risk more than you can afford to lose.
**Tim Sykes has a minority ownership stake in StockstoTrade.com.
The post Top Biotech Penny Stocks to Watch — July 14, 2021 appeared first on Timothy Sykes.